Kairos Pharma
KAPA
10 hedge funds and large institutions have $173K invested in Kairos Pharma in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
25% more funds holding
Funds holding: 8 → 10 (+2)
10.21% less ownership
Funds ownership: 11.51% → 1.3% (-10%)
88% less capital invested
Capital invested by funds: $1.46M → $173K (-$1.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$45.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$9.86K |
| 3 |
HF
HRT Financial
New York
|
+$9.63K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.85K |
| 5 |
Citigroup
New York
|
+$4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.31M |
| 2 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$45.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$12.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFG
1
SevenBridge Financial Group
Harrisburg,
Pennsylvania
| $49.6K | – | – | – |
|
|
XT
2
XTX Topco
George Town,
Cayman Islands
| $44.5K | +$45.7K | +62,746 | New |
|
|
ACA
3
Aptus Capital Advisors
Fairhope,
Alabama
| $31.4K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $15.5K | +$998 | +1,371 | +7% |
|
|
TSS
5
Two Sigma Securities
New York
| $9.61K | +$9.86K | +13,555 | New |
|
|
HF
6
HRT Financial
New York
| $9K | +$9.63K | +13,239 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $6.71K | +$4.85K | +6,666 | +239% |
|
|
8
Citigroup
New York
| $3.9K | +$4K | +5,499 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2.69K | +$2.76K | +3,797 | New |
|
10
Bank of America
Charlotte,
North Carolina
| $36 | +$22 | +30 | +143% |
|
|
AC
11
Armistice Capital
New York
| – | -$1.31M | -1,404,000 | Closed |
|
|
SRL
12
Scientech Research LLC
Jersey City,
New Jersey
| – | -$45.1K | -48,198 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$12.4K | -13,230 | Closed |
|
KAPA Hedge Fund Activity: Q2 2025 in Review
10 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Kairos Pharma (KAPA) for Q2 2025, worth a combined $173K — down 88% from $1.46M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new KAPA positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $45.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.31M sold.
- 10 institutional investors held Kairos Pharma (KAPA) as of Q2 2025, up from 8 in Q1 2025.
- Funds reported $173K of Kairos Pharma stock for Q2 2025, down 88% quarter-over-quarter.
- 5 funds opened new Kairos Pharma positions in Q2 2025 and 3 closed out, a net change of +2 holders.
- The largest Kairos Pharma buyer in Q2 2025 was XTX Topco, an estimated $45.7K added.
- The largest Kairos Pharma seller in Q2 2025 was Armistice Capital, an estimated $1.31M sold.
Based on aggregated 13F filings for Q2 2025.